Development and pathophysiological basis of thrombolytic therapy in acute myocardial infarction: Part I. 1912-1977 the controversy over the pathogenetic role of thrombus in acute myocardial infarction

Journal of Interventional Cardiology

Volumn 11, Issue 4, 1998, Pages 255-263

  Rentrop, K Peter ^a,b  

^a ST VINCENT S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY THROMBOSIS; COUNTERPULSATION; DOUBLE BLIND PROCEDURE; FIBRINOLYTIC THERAPY; HEART AFTERLOAD; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HISTOPATHOLOGY; HUMAN; INTIMA; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUBENDOTHELIUM; SURVIVAL TIME;

EID: 0031751504     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.1998.tb00128.x     Document Type: Review

References (47)

1. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912;59:2015-2020.
2. Blumgart HL, Schlesinger MJ, Davis D. Studies on the relation of the clinical manifestations of angina pectoris, coronary thrombosis, and myocardial infarction to the pathologic findings. Am Heart J 1940;19:1-91.
3. Libman E. The importance of blood examinations in the recognition of thrombosis of the coronary arteries and its sequelae. Am Heart J 1925;1:121-123.
4. Buechner F. Die Rolle des Herzmuskels bei der Angina pectoris. Beitr z path Anat u z allg Path 1932;89:644-667.
5. Friedberg CK, Horn H. Acute myocardial infarction not due to coronary artery occlusion. JAMA 1939;112:1675-1679.
6. Miller RD, Burchell HB, Edwards JE. Myocardial infarction withand without acute coronary occlusion. Arch Intern Med 1951;88:597-604.
7. Fletcher AP, Sherry S, Alkjaersig N. The maintenance of a sustained thrombolytic state in man I. Induction and effects. J Clin Invest 1959;38:1096-1110.
8. Fletcher AP, Sherry S, Alkjaersig N, et al. The maintenance of a sustained thrombolytic state in man II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 1959;38:1111-1119.
9. Branwood AW, Montgomery GL. Observations on the morbid anatomy of coronary artery disease. Scot Med J 1956;1:367-375.
10. Spain DM, Bradess VA. The relationship of coronary thrombosis to coronary atherosclerosis and ischemic heart disease. Am J Med Sci 1960;240:701-710.
11. Ehrlich JC, Shinohara Y. Low incidence of coronary thrombosis in myocardial infarction. Arch Pathol 1964;78:432-445.
12. Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. Am J Med 1972;52:425-443.
13. Popper L, Feiks FK Herzinfarkt und Koronarthrombose. Wien Klin Wochenschr 1961;73:421.
14. Erhardt LR, Lundman T, Mellstedt H. Incorporation of 1251-labelled fibrinogen into coronary arterial thrombi in acute myocardial infarction in man. Lancet 1973;1:387-390.
15. Roberts WC. The pathology of acute myocardial infarction. Hosp Pract 1971;12:89-104.
16. Walston A, Hackel DB, Estes EH. Acute coronary occlusion and the "power failure" syndrome. Am Heart J 1970;79:613-619.
17. Rude RE, Muller JE, Braunwald E. Efforts to limit the size of infarctions. Ann Intern Med 1981;95:736-761.
18. Lasch HG. Die Therapie des Herzinfarkts. Therapiewoche 1970;3:107-114.
19. Ruegsegger P, Nydik I, Abarquez R, et al. Effect of fibrinolytic (plasmin) therapy on the physiopathology of myocardial infarction. Am J Cardiol 1960;6:519-524.
20. Nydik I, Ruegsegger P, Bouvier C, et al. Salvage of heart muscle by fibrinolytic therapy after experimental coronary occlusion. Am Heart J 1961;61:93-100.
21. Neuhof H, Hey D, Glaser E, et al. Hemodynamic reactions induced by streptokinase therapy in patients with acute myocardial infarction. Eur J Intensive Care Med 1975;1:27-30.
22. European Cooperative Study Group. Streptokinase in acute myocardial infarction. N Engl J Med 1979;301:797-802.
23. Sullivan JM. Streptokinase and myocardial infarction. N Engl J Med 1979;301:836-837.
24. Cooperberg AA, Teitelbaum JI. The concentration of antihemophilic globulin (AHG) in patients with coronary artery disease. Ann Intern Med 1961;54:899-907.
25. Dintenfass L. Some rheologic factors in pathogenesis of thrombosis. Lancet 1965;2:370.
26. Benson RL. The present status of coronary arterial disease. Arch Pathol Lab Med 1926;2:876-916.
27. Koch W, Kong LC. Ueber die Formen des Coronarverschlusses, die Aenderungen im Coronarkreislauf und die Beziehungen zur Angina Pectoris. Beitr z Path Anat u z allg Path 1932;90:21-84.
28. Leary T. Experimental atherosclerosis in the rabbit compared with human (coronary) atherosclerosis. Arch Pathol 1934;17:453-492.
29. Saphir O, Priest WS, Hamburger WW, et al. Coronary arteriosclerosis, coronary thrombosis, and the resulting myocardial changes. An evaluation of their respective clinical pictures including the electrocardiographic records, based on the anatomical findings. Am Heart J 1935;10:567-595.
30. Paterson JC. Vascularization and hemorrhage of the intima of arteriosclerotic coronary arteries. Arch Pathol 1936; 22:313-324.
31. Paterson JC. Capillary rupture with intimai hemorrhage as a causative factor in coronary thrombus. Arch Pathol 1938;25:4744-4787.
32. Winternitz MC, Thomas RM, LeCompte PM. The Biology of Atherosclerosis. Springfield, IL: Charles C. Thomas, 1938.
33. Geiringer E. Intimai vascularization and atherosclerosis. J Path Bact 1951;63:201-211.
34. Geiringer F. The mural coronary. Am Heart J 1957;41: 359-368.
35. Sinapius D. Ueber Wandveraenderungen bei Coronarthrombose. Klin Wochenschr 1965;16:875-880.
36. Chapman I. Morphogenesis of occluding coronary artery thrombosis. Arch Pathol 1965;80:256-261.
37. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res 1966;6:1-17.
38. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: Characteristics of coronary atherosclerotic plaques underlying fatal exclusive thrombi. Br Heart J 1983;50:127-134.
39. Richardson PD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;2:941-944.
40. Cheng GC, Loree HM, Kamm RD, et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: A structural analysis with histopathological correlation. Circulation 1993;87:1179-1187.
41. Sinapius D. Beziehungen zwischen Koronarthrombosen und Myokardinfarkten. Dtsch Med Wochenschr 1972;12:443-48.
42. Chandler AB, Chapman I, Erhardt LR, et al. Coronary thrombosis in myocardial infarction. Am J Cardiol 1974; 34:823-833.
43. Sinapius D, Haeufigkeit und Morphologie der Coronarthrombose und ihre Beziehungen zur antithrombotischen und fibrinolytischen Behandlung. Klin Wochenschr 1965;43:37-43.
44. Favaloro RG, Effler DB, Cheanvechai C, et al. Acute coronary insufficiency (impending myocardial infarction and myocardial infarction): Surgical treatment by saphenous vein graft technique. Am J Cardiol 1971;28:598-605.
45. Berg R, Everhart FJ, Duvoisin G, et al. Operation for acute coronary occlusion. Am Surg 1976;42:517-521.
46. Hutter AM, Gold HK, Leinbach RC, et al. Various uses of intraaortic balloon pump in acute myocardial infarction: The first 24 hours in myocardial infarction. Witzstrock, New York-Baden-Baden-Koeln, 1977.
47. Bristow JD, Burchell HB, Campbell RW, et al. Report of the Ad Hoc committee on the indications forcoarteriography. Circulation 1977;55:969A-974A.